The Policy, Politics & Law of Cancer: Drug Development and the Cost of Researching and Treating Cancer

This panel, held on February 9, 2018, was part of the conference organized by the Solomon Center for Health Law and Policy at Yale Law School, Smilow Cancer Hospital, and Yale Cancer Center.

Charles Fuchs, MD, MPH—Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital

Peter Bach, MD, MAPP—Director of the Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
Gideon Blumenthal, MD—Deputy Director (acting), Office of Hematology Oncology Products, U.S. Food and Drug Administration
Levi Garraway, MD, PhD—Senior Vice President, Global Development & Medical Affairs, Eli Lilly; Director, Joint Center for Cancer Precision Medicine
Amy Kapczynski, JD—Professor of Law and Faculty Director, Global Health Justice Partnership, Yale Law School
Jeffrey Schwartz, MBA—Managing Director, Bain Capital Life Sciences
Ellen Sigal, PhD—Chairperson and Founder, Friends of Cancer Research

Invited Commentators:
Joseph Schlessinger, PhD—William H. Prusoff Professor of Pharmacology and Chair, Department of Pharmacology, Yale School of Medicine; Co-Director, Yale Cancer Biology Institute
James Stansel, JD: Executive Vice President and General Counsel, PhRMA